SeekingAlpha · Sep 26, 2026
electroCore Has A Line Of Sight At Cash Breakeven
electroCore shows improving financials and Quell growth, targeting 30%+ FY26 revenue. Click to read more about the Buy rating for ECOR.
EC
NASDAQ · ECOR
electroCore, Inc.
Healthcare · Medical - Devices
$9.92
Down-$0.21 (-2.07%)
Updated Oct 7, 2026, 5:01 AM
SID Score
5.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 39.09M
- P/E ratio
- -3.07
- Dividend yield
- 0.00%
- 52-week range
- $4.41 – $12.70
- Volume
- 39.72K
- Avg. volume
- 53.04K
Price performance · ECOR
ECOR price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
ECOR closed at $9.92 after 21 trading sessions, up 9.25% for the selected period.
- Last close
- $9.92
- Period change
- +9.25%
- Period low
- $8.99
- Period high
- $12.29
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $10.25 | $10.4499 | $9.89 | $9.92 | 39.72K |
| Oct 5, 2026 | $10.14 | $10.2499 | $9.90 | $10.13 | 31.99K |
| Oct 2, 2026 | $10.47 | $11.02 | $9.92 | $10.14 | 122.25K |
| Oct 1, 2026 | $11.00 | $11.0795 | $10.00 | $10.315 | 97.54K |
| Sep 30, 2026 | $10.725 | $11.0928 | $10.65 | $10.82 | 49.2K |
| Sep 29, 2026 | $11.16 | $11.3333 | $10.52 | $10.88 | 63.27K |
| Sep 28, 2026 | $11.00 | $11.28 | $10.7301 | $11.03 | 114.28K |
| Sep 25, 2026 | $11.34 | $11.4668 | $11.00 | $11.12 | 52.22K |
| Sep 24, 2026 | $11.43 | $11.74 | $11.18 | $11.35 | 68.92K |
| Sep 23, 2026 | $12.04 | $12.1309 | $11.25 | $11.42 | 113.31K |
| Sep 22, 2026 | $12.18 | $12.70 | $11.99 | $12.29 | 126.24K |
| Sep 21, 2026 | $11.74 | $12.12 | $11.35 | $11.995 | 120.28K |
| Sep 18, 2026 | $11.35 | $11.68 | $11.14 | $11.68 | 97.94K |
| Sep 17, 2026 | $10.80 | $11.93 | $10.4633 | $11.38 | 215.12K |
| Sep 16, 2026 | $10.07 | $10.68 | $9.86 | $10.65 | 137.36K |
| Sep 15, 2026 | $9.78 | $10.29 | $9.45 | $10.05 | 86.5K |
| Sep 14, 2026 | $9.60 | $9.9078 | $9.475 | $9.76 | 38.52K |
| Sep 11, 2026 | $9.185 | $9.99 | $9.185 | $9.62 | 40.22K |
| Sep 10, 2026 | $8.70 | $9.40 | $8.70 | $9.19 | 85.45K |
| Sep 9, 2026 | $8.90 | $9.19 | $8.90 | $8.99 | 26.98K |
| Sep 8, 2026 | $9.08 | $9.19 | $8.87 | $9.08 | 24.2K |
Latest ECOR news
The latest Smart Investors Daily articles mentioning ECOR.
Stock researchCompany · Overview
Company
Market Activity
Research & News
ECOR research
Overview
Company profile and research snapshot.
Company profile
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jan 26, 2026 | HC Wainwright & Co. | Buy | — |
| Mar 13, 2025 | Ladenburg Thalmann | Buy | — |
| Mar 13, 2025 | HC Wainwright & Co. | Buy | — |
| Dec 18, 2024 | HC Wainwright & Co. | Buy | — |
| Mar 14, 2024 | HC Wainwright & Co. | Buy | — |
News briefing
No generated briefing is available yet.
Yahoo · Sep 18, 2026
electroCore (ECOR) Stock Jumps 6.9%: Will It Continue to Soar?
electroCore (ECOR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Benzinga · Sep 18, 2026
Full Transcript: electroCore Q2 2026 Earnings Call
electroCore (NASDAQ:ECOR) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by Benzinga APIs. For
Yahoo · Sep 10, 2026
electroCore to Participate at H.C. Wainwright Global Investment Conference
ROCKAWAY, N.J., Sept. 10, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the H.C. Wainwright 28th Annual Global Investment Conference at the Lotte New York Palace Hotel. On Tuesday, September 15, 2026, Joshua Lev, Co-CEO, President and CFO, will participate in a fireside chat and host one-on-one meetings with investors during the conference. Investors who wish to reques
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
